
Big study ties Cialis for enlarged prostate to a modest glaucoma risk; eye exams advised
An observational study of 73,854 men suggests daily tadalafil (Cialis) for enlarged prostate is associated with a small increase in glaucoma, ocular hypertension, and related treatment initiation over five years (3.93% vs 3.16%, about 8 extra cases per 1,000 men). The study can show only association, not causation, and most participants were White, but the finding warrants routine eye checks—especially for those with glaucoma risk factors—rather than stopping the medication. Medicare coverage details and exam logistics are provided, but the key takeaway is to schedule annual dilated eye exams and discuss risks with your doctor rather than discontinue therapy.





